Showing results (201-210 of 666) with videos related to
Sort By:
Pageof 67
Blood|December 11, 2008
Acquired variation outweighs inherited variation in whole genome analysis of methotrexate polyglutamate accumulation in leukemiaDeborah French, Wenjian Yang, Cheng Cheng, et al.Pediatric Blood & Cancer|November 1, 2011
Lessons from the past: opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignanciesMelissa M Hudson, Joseph P Neglia, William G Woods, et al.Pediatric Blood & Cancer|December 31, 2016
Osteonecrosis is unrelated to hip anatomy in children with acute lymphoblastic leukemiaMary V Portera, Seth E Karol, Colton Smith, et al.Cancer Chemotherapy and Pharmacology|February 28, 2024
Ommaya reservoir use in pediatric ALL and NHL: a review at St. Jude Children's Research HospitalAlyssa Gaietto, John C Panetta, Jennifer L Pauley, et al.Pediatric Blood & Cancer|February 19, 2013
Successful treatment of pediatric plasmacytoid dendritic cell tumors with a contemporary regimen for acute lymphoblastic leukemiaKaren D Wright, Mihaela M Onciu, Elaine Coustan-Smith, et al.Blood|March 23, 2010
Clinical significance of low levels of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemiaPatricia Stow, Laura Key, Xiaohua Chen, et al.Archives of Physical Medicine and Rehabilitation|May 31, 2011
Association of muscle strength and bone mineral density in adult survivors of childhood acute lymphoblastic leukemiaEmily D Joyce, Vikki G Nolan, Kirsten K Ness, et al.Cancer Chemotherapy and Pharmacology|November 20, 2002
A mathematical model of in vivo methotrexate accumulation in acute lymphoblastic leukemiaJohn Carl Panetta, Yuri Yanishevski, Ching-Hon Pui, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2014
NK cell genotype and phenotype at diagnosis of acute lymphoblastic leukemia correlate with postinduction residual diseaseErin M Sullivan, Sima Jeha, Guolian Kang, et al.Cancer|November 4, 2009
Combination of cladribine plus topotecan for recurrent or refractory pediatric acute myeloid leukemiaHiroto Inaba, Clinton F Stewart, Kristine R Crews, et al.Pageof 67